DK0666477T3 - Apparat til detektering af Downs syndrom ved hjælp af non-invasiv maternel blodscreening - Google Patents

Apparat til detektering af Downs syndrom ved hjælp af non-invasiv maternel blodscreening

Info

Publication number
DK0666477T3
DK0666477T3 DK95104733T DK95104733T DK0666477T3 DK 0666477 T3 DK0666477 T3 DK 0666477T3 DK 95104733 T DK95104733 T DK 95104733T DK 95104733 T DK95104733 T DK 95104733T DK 0666477 T3 DK0666477 T3 DK 0666477T3
Authority
DK
Denmark
Prior art keywords
down syndrome
maternal blood
blood screening
reference data
pregnant woman
Prior art date
Application number
DK95104733T
Other languages
English (en)
Inventor
James N Macri
Original Assignee
Jn Macri Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27540826&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0666477(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jn Macri Technologies Llc filed Critical Jn Macri Technologies Llc
Application granted granted Critical
Publication of DK0666477T3 publication Critical patent/DK0666477T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Immunology (AREA)
  • Data Mining & Analysis (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Geophysics And Detection Of Objects (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Image Processing (AREA)
  • Paper (AREA)
  • Tests Of Electronic Circuits (AREA)
DK95104733T 1989-01-17 1990-01-16 Apparat til detektering af Downs syndrom ved hjælp af non-invasiv maternel blodscreening DK0666477T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US29748189A 1989-01-17 1989-01-17
US31180889A 1989-02-17 1989-02-17
US34937389A 1989-05-08 1989-05-08
US36060389A 1989-06-02 1989-06-02
US42077589A 1989-10-12 1989-10-12

Publications (1)

Publication Number Publication Date
DK0666477T3 true DK0666477T3 (da) 2004-02-23

Family

ID=27540826

Family Applications (2)

Application Number Title Priority Date Filing Date
DK90903086T DK0409956T4 (da) 1989-01-17 1990-01-16 Down's syndrom-screeningmetode
DK95104733T DK0666477T3 (da) 1989-01-17 1990-01-16 Apparat til detektering af Downs syndrom ved hjælp af non-invasiv maternel blodscreening

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK90903086T DK0409956T4 (da) 1989-01-17 1990-01-16 Down's syndrom-screeningmetode

Country Status (9)

Country Link
US (1) US5324668A (da)
EP (2) EP0666477B1 (da)
JP (1) JP2644373B2 (da)
AT (2) ATE252240T1 (da)
AU (1) AU629908B2 (da)
DE (2) DE69034111T2 (da)
DK (2) DK0409956T4 (da)
ES (2) ES2084689T5 (da)
WO (1) WO1990008325A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252489A (en) * 1989-01-17 1993-10-12 Macri James N Down syndrome screening method utilizing dried blood samples
ATE252240T1 (de) * 1989-01-17 2003-11-15 Jn Macri Technologies Llc Inc Einrichtung zum nachweis vom down syndrom durch nichtinvasive siebtestung des mütterlichen blutes
US5324667A (en) * 1989-01-17 1994-06-28 Macri James N Method for detecting down sydrown by non-invasive maternal blood screening
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
GB9224965D0 (en) * 1992-11-28 1993-01-20 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9306354D0 (en) * 1993-03-26 1993-05-19 Kodak Ltd Antenatal screening for chromosomal abnormalities
US5583612A (en) * 1994-07-14 1996-12-10 Xerox Corporation Flexible latch with relaxed engagement
GB9315230D0 (en) * 1993-07-22 1993-09-08 Kodak Ltd Antenatal screening for chromosomal abnormalities
JP3703858B2 (ja) * 1993-09-30 2005-10-05 シスメックス株式会社 帰属度判別装置
GB9416415D0 (en) * 1994-08-13 1994-10-05 Kodak Ltd Antenatel screening for pregnacy abnormalities
US5606164A (en) * 1996-01-16 1997-02-25 Boehringer Mannheim Corporation Method and apparatus for biological fluid analyte concentration measurement using generalized distance outlier detection
GB9606261D0 (en) * 1996-03-25 1996-05-29 Johnson & Johnson Clin Diag Prenatal screening for fetal abnormalities
US5888740A (en) * 1997-09-19 1999-03-30 Genaco Biomedical Products, Inc. Detection of aneuploidy and gene deletion by PCR-based gene- dose co-amplification of chromosome specific sequences with synthetic sequences with synthetic internal controls
PT1076824E (pt) 1998-04-29 2006-10-31 Wald Nicholas John Avaliacao pre-natal do sindroma de down
US7041466B2 (en) * 2002-08-05 2006-05-09 Auburn University Mouse disease model for evaluation of prophylactic and therapeutic treatments of Chlamydia
US7315787B2 (en) * 2003-10-07 2008-01-01 Ntd Laboratories, Inc. Multi-marker screening protocol for fetal abnormalities
EP1689884A4 (en) * 2003-10-08 2007-04-04 Univ Boston METHODS OF PRENATAL DIAGNOSIS OF CHROMOSOMIC ANOMALIES
CA2602963A1 (en) * 2005-03-24 2006-09-28 Beth Israel Deaconess Medical Center Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
US20080117416A1 (en) * 2006-10-27 2008-05-22 Hunter Ian W Use of coherent raman techniques for medical diagnostic and therapeutic purposes, and calibration techniques for same
WO2011144999A1 (en) 2010-05-17 2011-11-24 Sandra Reznik Plasma protein-a2 (papp-a2) as a marker for detecting risk of chromosomal abnormalities
CN103076458A (zh) * 2012-12-16 2013-05-01 北京利德曼生化股份有限公司 游离人绒毛膜***β亚单位磁微粒化学发光法定量测定试剂盒及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016250A (en) * 1974-03-22 1977-04-05 Cornell Research Foundation, Inc. Method for testing for pregnancy
US4123224A (en) * 1975-12-17 1978-10-31 American Home Products Corporation Diagnostic test device
JPS54126723A (en) * 1978-03-23 1979-10-02 Teikoku Hormone Mfg Co Ltd Preparation of specific hcg and specific anti-hcg-beta-subunit antibody
DE3112767A1 (de) * 1981-03-31 1982-11-11 Werner Dr.med. 1000 Berlin Steinschulte Heimcomputer zur natuerlichen familienplanung (nfp) und zur gynaekologisch-endokrinologischen diagnostik
US4565687A (en) * 1981-11-16 1986-01-21 The Reagents Of The University Of Michigan Monoclonal antibodies specific for the unbound β subunit of human chorionic gonadotropin
GR850899B (da) * 1984-04-12 1985-11-25 Gen Hospital Corp
US4874693A (en) * 1986-10-10 1989-10-17 Mark Bogart Method for assessing placental dysfunction
ATE91182T1 (de) * 1987-07-09 1993-07-15 3I Res Expl Ltd Praenatales screening fuer downs-syndrom.
US5037305A (en) * 1988-11-16 1991-08-06 Vivigen, Inc. Graphic method for reporting risk to a patient
ATE252240T1 (de) * 1989-01-17 2003-11-15 Jn Macri Technologies Llc Inc Einrichtung zum nachweis vom down syndrom durch nichtinvasive siebtestung des mütterlichen blutes

Also Published As

Publication number Publication date
JPH03505128A (ja) 1991-11-07
DE69034111D1 (de) 2003-11-20
DE69026153D1 (en) 1996-05-02
DK0409956T3 (da) 1996-04-29
EP0409956A1 (en) 1991-01-30
AU5093690A (en) 1990-08-13
JP2644373B2 (ja) 1997-08-25
ES2084689T5 (es) 2005-03-01
EP0666477B1 (en) 2003-10-15
DK0409956T4 (da) 2004-09-06
DE69034111T2 (de) 2004-07-29
DE69026153T3 (de) 2005-05-12
DE69026153T2 (de) 1996-09-19
EP0409956B1 (en) 1996-03-27
ES2210266T3 (es) 2004-07-01
ATE252240T1 (de) 2003-11-15
US5324668A (en) 1994-06-28
AU629908B2 (en) 1992-10-15
ATE136121T1 (de) 1996-04-15
EP0666477A1 (en) 1995-08-09
WO1990008325A1 (en) 1990-07-26
EP0409956B2 (en) 2004-07-21
ES2084689T3 (es) 1996-05-16

Similar Documents

Publication Publication Date Title
DK0666477T3 (da) Apparat til detektering af Downs syndrom ved hjælp af non-invasiv maternel blodscreening
Reneman et al. Age-related changes in carotid artery wall properties in men
O'Brien et al. Growth of the ultrasound fetal femur length during normal pregnancy: part I
Bree et al. Transvaginal sonography in the evaluation of normal early pregnancy: correlation with HCG level
Exner et al. Introduction to Quantitative Structural Analysis.(Einfuhrung in die Quantitative Gefugeanalyse)
IL139302A (en) Antenatal screening for down's syndrome
ATE200020T1 (de) Vorrichtung zur detektion elektromagnetischer reflexion von biologischen gewebe
ES2158870T3 (es) Dispositivo sensor para la medicion de parametros vitales de un feto durante el parto.
ES469438A1 (es) Una sonda vaginal
DK0923730T3 (da) Prænatal screening for Down's syndrom ved anvendelse af hyperglykosyleret gonadotropin
BR8606860A (pt) Processo de imunoensaio para detectar antigeno associado de um carcinoma humano em uma amostra patologica,conjunto para teste de imunoensaio,teste de imunoensaio e processo para identificar marcadores de tumores sosidos em tecido neoplastico
ATE163971T1 (de) Verfahren zur isolierung von fetalen zytotrophoblastzellen
ATE227024T1 (de) Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut
ATE91182T1 (de) Praenatales screening fuer downs-syndrom.
ES2067024T3 (es) Metodo y kit para determinar actividades fosforilantes y desfosforilantes de tirosina.
WO1999054707A3 (en) Fetal testing for prediction of low birth weight
Kanisius et al. Is the complexity of the human sagittal suture related to the size of the temporal muscle?
RU2095817C1 (ru) Способ прогнозирования образования кист яичников у девочек в препубертатном и пубертатном периоде
Madrid et al. Circumflex occlusion and posterior myocardial infarction: Diagnostic criteria and automated ECG analysis programs
SU1482682A1 (ru) Устройство дл наружного измерени беременной матки
SU1448281A1 (ru) Способ диагностики волчаночного нефрита
Merilan Bovine pregnancy detection by nuclear magnetic resonance spectra of cervical mucus
Bardach et al. The role of photoplethysmography in the prediction of the experimental flap survival
SU554480A1 (ru) Прибор дл определени прочности образцов на сжатие
RU93036133A (ru) Способ определения состояния плода